Investing Profile

Peter Bisgaard

InvestorVC
Managing Director at Nan Fung Life Sciences
pivotalbiovp.com/team-members...San Francisco Bay Area
Photo of Peter Bisgaard, Managing Director at Nan Fung Life Sciences
Your Intro Paths to Peter Bisgaard

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Networks Peter is a member of
Novo Holdings Network
17 CONNECTIONS
DTU - Technical University of Denmark Network
15 CONNECTIONS
McKinsey & Co. Network
12 CONNECTIONS
McKinsey & Co. Network
12 CONNECTIONS

Find Peter Bisgaard on

cb
Current Investing Position
Nan Fung Life Sciences Managing Director
Investment Range
$100K - $5.0M
Sweet Spot
$1.5M
Investments On Record
20

Peter Bisgaard is on these Sector & Stage Rankings

Peter Bisgaard's Investments On Record (11)

CompanyStageDateRound SizeTotal Raised
Addition Therapeutics
Series ADec 2025$100M
$100M
Co-investors: Jayson Punwani (Abingworth), Jennifer Lee (Pivotal bioVenture Partners)
Engrail Therapeutics
Series BMar 2024$170M
Series AAug 2021$32M
Series AJun 2020$32M
$230M
Co-investors: Stacie Weninger (F-Prime Capital Partners), Heath Lukatch (Novo Holdings), Jasper Bos (Forbion), Niall O’Donnell (RiverVest Venture Partners)
Oculis
Series CMay 2021$57M
Series BJan 2019$16M
$190M
Co-investors: Rob Hopfner (Pivotal Life Sciences), Lionel Carnot (Earlybird Venture Capital), Florent Gros (Earlybird Venture Capital), Zhi Yang (BVCF (Bioveda China Fund))
Eargo
Series EJul 2020$82M
Series DMar 2019$52M
Series COct 2017$45M
$220M
Co-investors: Pierre Lamond (Khosla Ventures), Josh Makower (New Enterprise Associates (NEA)), David Wu (Maveron), Juliet Tammenoms Bakker (Longitude Capital), Ben Capell (Peterson Ventures), Dan Levitan (Maveron LLC), Farzad Nazem
OncXerna Therapeutics
Series BJun 2019$80M
$80M
Ceterix Orthopaedics
Series BMay 2014$18M
$18M
Co-investors: Charles Warden (SV Health Investors)
Otonomy
Series DApr 2014$49M
Series CSep 2013$46M
Series BAug 2010$39M
Series BAug 2010$39M
$180M
Co-investors: Chau Khuong (OrbiMed), Brian Dovey (Domain Associates), John McKearn (RiverVest Venture Partners), Niall O’Donnell (RiverVest Venture Partners), Heather Preston (Oxonian Ventures ), Jay Lichter (Madrona Venture Group), Bill Harrington (Osage University Partners (OUP))
Nevro
Series CMar 2013$48M
$130M
Co-investors: Asish Xavier (Johnson & Johnson Innovation), Paul Klingenstein (Aberdare Ventures)

Peter Bisgaard's Experience

Managing Director Nan Fung Life Sciences2017 - Present
Consultant McKinsey & Co.Present
Managing Director McKinsey & Co.Present
Senior Partner Novo HoldingsPresent

Peter Bisgaard's Education

DTU - Technical University of Denmark M.Sc. Engineering

Investors who invest with Peter Bisgaard

Sign in with Google →

Scouts & Angels Affiliated With Peter Bisgaard

Sign in with Google →